Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol (Q71657509)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

L Roy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

J Mehta

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

P Mehta

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

language of work or name

English

0 references

publication date

1 February 1983

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

20 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

464-467

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Stability of prostaglandin I2 in human blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

On the formation and effects of thromboxane A2 in human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Thromboxanes: selective biosynthesis and distinct biological properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Antagonism of the effects of furosemide by in domethacin in normal and hypertensive man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Modification of antihypertensive effect of beta-adrenoceptor-blocking agents by inhibition of endogenous prostaglandin synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Impaired renal production of prostaglandin E2: A newly identified lesion in human essential hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Production of prostacyclin-like substance in stroke-prone and stroke-resistant spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Enhanced formation of PGI2, a potent hypotensive substance, by aortic rings and homogenates of the spontaneously hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Clinical investigation of an antagonist at alpha- and beta-adrenoceptors-AH5158A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Dipyridamole and Aspirin in Relation to Platelet Aggregation and Vessel Wall Prostaglandin Generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Release of prostacyclin into the bloodstream and its exhaustion in humans after local blood flow changes (ischemia and venous stasis)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Platelet function in hypertension and effect of therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2883%2980081-2

10.1016/S0002-9149(83)80081-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6823861%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference